Industry & Policy News

[National Institutes of Health] The National Institutes of Health (NIH) has launched a clinical trials network to evaluate emerging technologies for cancer screening.

Iovance Biotherapeutics, Inc. announced that the US FDA has approved AMTAGVI™ suspension for intravenous infusion. [nan] Press Release

[The University of Iowa] Stephanie Gantz, Carver College of Medicine assistant professor in molecular physiology and biophysics, was named one of the 2024 Sloan Research Fellows by the Alfred P. Sloan Foundation.

[Mirage News] The Wiley Foundation announced that the 22nd annual Wiley Prize in Biomedical Sciences will be awarded to Judith Kimble, Allan Spradling, and Raymond Schofield for their discovery of the stem cell niche, a localized environment that controls stem cell identity.

[Regulatory Affairs Professionals Society] The US FDA is several weeks late in issuing guidance on how and when drug and device companies must submit diversity action plans for clinical trial research.

[NMDP (Globe News Wire)] NMDPSM announced the enrollment of the first patient in the groundbreaking OPTIMIZE clinical trial. The trial was sponsored by NMDP through the Center for International Blood and Marrow Transplant Research.